FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2799690470> ?p ?o ?g. }

• W2799690470 abstract "Abstract Background Anaplastic lymphoma kinase (ALK)‐positive anaplastic large cell lymphoma (ALCL) shows 60–70% event free survival with standard treatments. Targeted therapies are being tested for increased benefit and/or reduced toxicity, but interactions with standard agents are not well known. Methods We exposed four ALCL cell lines to two targeted agents, crizotinib and brentuximab vedotin, and to two standard agents, doxorubicin and vinblastine. For each agent and combination, we measured apoptosis and expression of approximately 300 previously annotated genes of interest using targeted RNA‐sequencing. An aurora kinase inhibitor, alisertib, was similarly tested for gene expression effects. Results Only crizotinib, alone or in combination, showed significant effects (adjusted P < 0.05) on expression and apoptosis. One hundred and nine of 277 gene expressions showed crizotinib‐associated differential expression, mostly downregulation, 62 associated with apoptosis, and 28 associated with both crizotinib and apoptosis. Doxorubicin was antagonistic with crizotinib on gene expression and apoptosis. Brentuximab was synergistic with crizotinib in apoptosis, and not antagonistic in gene expression. Vinblastine also appeared synergistic with crizotinib but did not achieve statistical significance. Alisertib did not show significant expression changes. Conclusions Our data suggest that crizotinib induces apoptosis through orderly changes in cell signaling associated with ALK inhibition. Expression effects of crizotinib and associated apoptosis are antagonized by doxorubicin, but apoptosis is synergized by brentuximab vedotin and possibly vinblastine. These findings suggest that concurrent use of crizotinib and doxorubicin may be counterproductive, while the pairing of crizotinib with brentuximab (or vinblastine) may increase efficacy. Alisertib did not induce expression changes at cytotoxic dosage." @default.
• W2799690470 created "2018-05-17" @default.
• W2799690470 creator A5023092047 @default.
• W2799690470 creator A5036601065 @default.
• W2799690470 creator A5043975470 @default.
• W2799690470 creator A5048937062 @default.
• W2799690470 creator A5074187518 @default.
• W2799690470 creator A5084528838 @default.
• W2799690470 date "2018-04-26" @default.
• W2799690470 modified "2023-09-27" @default.
• W2799690470 title "Crizotinib induces apoptosis and gene expression changes in ALK+ anaplastic large cell lymphoma cell lines; brentuximab synergizes and doxorubicin antagonizes" @default.
• W2799690470 cites W1554739819 @default.
• W2799690470 cites W1801993810 @default.
• W2799690470 cites W1826590463 @default.
• W2799690470 cites W1939376872 @default.
• W2799690470 cites W1964092159 @default.
• W2799690470 cites W1968351069 @default.
• W2799690470 cites W1969914656 @default.
• W2799690470 cites W1979532351 @default.
• W2799690470 cites W1988757730 @default.
• W2799690470 cites W1990152951 @default.
• W2799690470 cites W1993428519 @default.
• W2799690470 cites W1998074965 @default.
• W2799690470 cites W2000371328 @default.
• W2799690470 cites W2011118089 @default.
• W2799690470 cites W2017712465 @default.
• W2799690470 cites W2019103098 @default.
• W2799690470 cites W2021247755 @default.
• W2799690470 cites W2027767232 @default.
• W2799690470 cites W2030560697 @default.
• W2799690470 cites W2031196045 @default.
• W2799690470 cites W2036495835 @default.
• W2799690470 cites W2038586807 @default.
• W2799690470 cites W2041445130 @default.
• W2799690470 cites W2041652923 @default.
• W2799690470 cites W2046455004 @default.
• W2799690470 cites W2047559912 @default.
• W2799690470 cites W2049156458 @default.
• W2799690470 cites W2051083170 @default.
• W2799690470 cites W2054073136 @default.
• W2799690470 cites W2067466153 @default.
• W2799690470 cites W2072953725 @default.
• W2799690470 cites W2079523831 @default.
• W2799690470 cites W2087516193 @default.
• W2799690470 cites W2089121900 @default.
• W2799690470 cites W2096173332 @default.
• W2799690470 cites W2107853162 @default.
• W2799690470 cites W2109078648 @default.
• W2799690470 cites W2125245219 @default.
• W2799690470 cites W2127304877 @default.
• W2799690470 cites W2128710193 @default.
• W2799690470 cites W2135436790 @default.
• W2799690470 cites W2139526378 @default.
• W2799690470 cites W2139891818 @default.
• W2799690470 cites W2146512944 @default.
• W2799690470 cites W2148654292 @default.
• W2799690470 cites W2150424194 @default.
• W2799690470 cites W2151675157 @default.
• W2799690470 cites W2156134727 @default.
• W2799690470 cites W2156226322 @default.
• W2799690470 cites W2156506990 @default.
• W2799690470 cites W2158706332 @default.
• W2799690470 cites W2160410546 @default.
• W2799690470 cites W2160516333 @default.
• W2799690470 cites W2164121384 @default.
• W2799690470 cites W2174906016 @default.
• W2799690470 cites W2210753338 @default.
• W2799690470 cites W2281041882 @default.
• W2799690470 cites W2289272475 @default.
• W2799690470 cites W2301188205 @default.
• W2799690470 cites W2309066327 @default.
• W2799690470 cites W2317055602 @default.
• W2799690470 cites W2418974390 @default.
• W2799690470 cites W2529342355 @default.
• W2799690470 cites W2552037618 @default.
• W2799690470 cites W2591412015 @default.
• W2799690470 cites W2740071091 @default.
• W2799690470 cites W4231972204 @default.
• W2799690470 cites W4235361141 @default.
• W2799690470 cites W4237674422 @default.
• W2799690470 cites W59910900 @default.
• W2799690470 doi "https://doi.org/10.1002/pbc.27094" @default.
• W2799690470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29697184" @default.
• W2799690470 hasPublicationYear "2018" @default.
• W2799690470 type Work @default.
• W2799690470 sameAs 2799690470 @default.
• W2799690470 citedByCount "6" @default.
• W2799690470 countsByYear W27996904702019 @default.
• W2799690470 countsByYear W27996904702020 @default.
• W2799690470 countsByYear W27996904702021 @default.
• W2799690470 countsByYear W27996904702023 @default.
• W2799690470 crossrefType "journal-article" @default.
• W2799690470 hasAuthorship W2799690470A5023092047 @default.
• W2799690470 hasAuthorship W2799690470A5036601065 @default.
• W2799690470 hasAuthorship W2799690470A5043975470 @default.
• W2799690470 hasAuthorship W2799690470A5048937062 @default.
• W2799690470 hasAuthorship W2799690470A5074187518 @default.
• W2799690470 hasAuthorship W2799690470A5084528838 @default.
• W2799690470 hasConcept C117643217 @default.
• W2799690470 hasConcept C126322002 @default.

• next